Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine

Lee E. Dunlap, Anne M. Andrews, David Olson

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Better known as "ecstasy", 3,4-methylenedioxymethamphetamine (MDMA) is a small molecule that has played a prominent role in defining the ethos of today's teenagers and young adults, much like lysergic acid diethylamide (LSD) did in the 1960s. Though MDMA possesses structural similarities to compounds like amphetamine and mescaline, it produces subjective effects that are unlike any of the classical psychostimulants or hallucinogens and is one of the few compounds capable of reliably producing prosocial behavioral states. As a result, MDMA has captured the attention of recreational users, the media, artists, psychiatrists, and neuropharmacologists alike. Here, we detail the synthesis of MDMA as well as its pharmacology, metabolism, adverse effects, and potential use in medicine. Finally, we discuss its history and why it is perhaps the most important compound for the future of psychedelic science - having the potential to either facilitate new psychedelic research initiatives, or to usher in a second Dark Age for the field.

Original languageEnglish (US)
Pages (from-to)2408-2427
Number of pages20
JournalACS Chemical Neuroscience
Volume9
Issue number10
DOIs
StatePublished - Oct 17 2018

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Neurosciences
Hallucinogens
Mescaline
Lysergic Acid Diethylamide
Bioelectric potentials
Amphetamine
Metabolism
Medicine
Psychiatry
Young Adult
History
Pharmacology
Molecules
Research

Keywords

  • 3,4-methylenedioxymethamphetamine
  • empathogen
  • entactogen
  • MDMA
  • psychedelic

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this

Dark Classics in Chemical Neuroscience : 3,4-Methylenedioxymethamphetamine. / Dunlap, Lee E.; Andrews, Anne M.; Olson, David.

In: ACS Chemical Neuroscience, Vol. 9, No. 10, 17.10.2018, p. 2408-2427.

Research output: Contribution to journalReview article

Dunlap, Lee E. ; Andrews, Anne M. ; Olson, David. / Dark Classics in Chemical Neuroscience : 3,4-Methylenedioxymethamphetamine. In: ACS Chemical Neuroscience. 2018 ; Vol. 9, No. 10. pp. 2408-2427.
@article{075eafd3176a46ef869b726f4e905fd5,
title = "Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine",
abstract = "Better known as {"}ecstasy{"}, 3,4-methylenedioxymethamphetamine (MDMA) is a small molecule that has played a prominent role in defining the ethos of today's teenagers and young adults, much like lysergic acid diethylamide (LSD) did in the 1960s. Though MDMA possesses structural similarities to compounds like amphetamine and mescaline, it produces subjective effects that are unlike any of the classical psychostimulants or hallucinogens and is one of the few compounds capable of reliably producing prosocial behavioral states. As a result, MDMA has captured the attention of recreational users, the media, artists, psychiatrists, and neuropharmacologists alike. Here, we detail the synthesis of MDMA as well as its pharmacology, metabolism, adverse effects, and potential use in medicine. Finally, we discuss its history and why it is perhaps the most important compound for the future of psychedelic science - having the potential to either facilitate new psychedelic research initiatives, or to usher in a second Dark Age for the field.",
keywords = "3,4-methylenedioxymethamphetamine, empathogen, entactogen, MDMA, psychedelic",
author = "Dunlap, {Lee E.} and Andrews, {Anne M.} and David Olson",
year = "2018",
month = "10",
day = "17",
doi = "10.1021/acschemneuro.8b00155",
language = "English (US)",
volume = "9",
pages = "2408--2427",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Dark Classics in Chemical Neuroscience

T2 - 3,4-Methylenedioxymethamphetamine

AU - Dunlap, Lee E.

AU - Andrews, Anne M.

AU - Olson, David

PY - 2018/10/17

Y1 - 2018/10/17

N2 - Better known as "ecstasy", 3,4-methylenedioxymethamphetamine (MDMA) is a small molecule that has played a prominent role in defining the ethos of today's teenagers and young adults, much like lysergic acid diethylamide (LSD) did in the 1960s. Though MDMA possesses structural similarities to compounds like amphetamine and mescaline, it produces subjective effects that are unlike any of the classical psychostimulants or hallucinogens and is one of the few compounds capable of reliably producing prosocial behavioral states. As a result, MDMA has captured the attention of recreational users, the media, artists, psychiatrists, and neuropharmacologists alike. Here, we detail the synthesis of MDMA as well as its pharmacology, metabolism, adverse effects, and potential use in medicine. Finally, we discuss its history and why it is perhaps the most important compound for the future of psychedelic science - having the potential to either facilitate new psychedelic research initiatives, or to usher in a second Dark Age for the field.

AB - Better known as "ecstasy", 3,4-methylenedioxymethamphetamine (MDMA) is a small molecule that has played a prominent role in defining the ethos of today's teenagers and young adults, much like lysergic acid diethylamide (LSD) did in the 1960s. Though MDMA possesses structural similarities to compounds like amphetamine and mescaline, it produces subjective effects that are unlike any of the classical psychostimulants or hallucinogens and is one of the few compounds capable of reliably producing prosocial behavioral states. As a result, MDMA has captured the attention of recreational users, the media, artists, psychiatrists, and neuropharmacologists alike. Here, we detail the synthesis of MDMA as well as its pharmacology, metabolism, adverse effects, and potential use in medicine. Finally, we discuss its history and why it is perhaps the most important compound for the future of psychedelic science - having the potential to either facilitate new psychedelic research initiatives, or to usher in a second Dark Age for the field.

KW - 3,4-methylenedioxymethamphetamine

KW - empathogen

KW - entactogen

KW - MDMA

KW - psychedelic

UR - http://www.scopus.com/inward/record.url?scp=85054973916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054973916&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.8b00155

DO - 10.1021/acschemneuro.8b00155

M3 - Review article

C2 - 30001118

AN - SCOPUS:85054973916

VL - 9

SP - 2408

EP - 2427

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 10

ER -